Literature DB >> 17312213

Emergency use of sugammadex after failure of standard reversal drugs.

Adam Lenz1, Gary Hill, Paul F White.   

Abstract

Administration of sugammadex, 350 mg IV (4 mg/kg), in the postanesthesia care unit immediately (<60 s) relieved acute respiratory distress due to residual neuromuscular blockade in a 42-yr-old patient with chronic renal failure who had received vecuronium, 10 mg IV, for tracheal intubation, after inadequate reversal of neuromuscular blockade in the operating room with neostigmine, 5 mg IV, and glycopyrrolate, 1 mg IV.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17312213     DOI: 10.1213/01.ane.0000253231.76654.45

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  4 in total

Review 1.  Perioperative Care of Elderly Surgical Outpatients.

Authors:  Xuezhao Cao; Paul F White; Hong Ma
Journal:  Drugs Aging       Date:  2017-09       Impact factor: 3.923

Review 2.  Sugammadex: A Review of Neuromuscular Blockade Reversal.

Authors:  Gillian M Keating
Journal:  Drugs       Date:  2016-07       Impact factor: 9.546

3.  A miracle that accelerates operating room functionality: sugammadex.

Authors:  Erdal Dogan; Mehmet Salim Akdemir; Abdulmenap Guzel; Mehmet Besir Yildirim; Zeynep Baysal Yildirim; Mahir Kuyumcu; Abdurrahman Gümüş; Hakan Akelma
Journal:  Biomed Res Int       Date:  2014-08-14       Impact factor: 3.411

4.  Sugammadex for reversal of neuromuscular blockade: a retrospective analysis of clinical outcomes and cost-effectiveness in a single center.

Authors:  Michele Carron; Fabio Baratto; Francesco Zarantonello; Carlo Ori
Journal:  Clinicoecon Outcomes Res       Date:  2016-02-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.